0000899243-21-049171.txt : 20211221 0000899243-21-049171.hdr.sgml : 20211221 20211221160534 ACCESSION NUMBER: 0000899243-21-049171 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211220 FILED AS OF DATE: 20211221 DATE AS OF CHANGE: 20211221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gros David-Alexandre C CENTRAL INDEX KEY: 0001644489 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36620 FILM NUMBER: 211509170 MAIL ADDRESS: STREET 1: 220 MARLBOROUGH STREET STREET 2: #6 CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eledon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001404281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 949-238-8090 MAIL ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: Novus Therapeutics, Inc. DATE OF NAME CHANGE: 20170511 FORMER COMPANY: FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc DATE OF NAME CHANGE: 20070622 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-20 0 0001404281 Eledon Pharmaceuticals, Inc. ELDN 0001644489 Gros David-Alexandre C C/O ELEDON PHARMACEUTICALS, INC. 19900 MACARTHUR BLVD., IRVINE CA 92612 1 1 0 0 Chief Executive Officer Common Stock 2021-12-20 4 P 0 2000 4.48 A 9000 D These shares were purchased in an open market transaction in accordance with the Issuer's trading policies. /s/ Ryan A. Murr, as attorney-in-fact for David-Alexandre Gros 2021-12-21